🇺🇸 Caribou Biosciences, Inc.CRBU
Get Caribou Biosciences, Inc. filings on Telegram the moment they are published.
Follow Caribou Biosciences, Inc. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 2.05, 5.02, 7.01, 8.01, 9.01
Overview: Caribou Biosciences is exploring strategic alternatives, discontinuing vispa-cel and CB-011 programs, and implementing workforce reductions following $113.8 million in cash as of June 30, 2026.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest